27,810 Shares in Humana Inc. (NYSE:HUM) Acquired by Kennondale Capital Management LLC

Kennondale Capital Management LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,810 shares of the insurance provider's stock, valued at approximately $7,056,000. Humana accounts for about 5.7% of Kennondale Capital Management LLC's portfolio, making the stock its 3rd biggest holding.

Several other large investors have also made changes to their positions in HUM. FPC Investment Advisory Inc. acquired a new position in Humana in the fourth quarter valued at about $27,000. Centricity Wealth Management LLC acquired a new position in Humana in the fourth quarter valued at about $30,000. LFA Lugano Financial Advisors SA lifted its stake in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after buying an additional 45 shares during the period. OFI Invest Asset Management acquired a new position in Humana in the fourth quarter valued at about $33,000. Finally, Atwood & Palmer Inc. lifted its stake in Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after buying an additional 60 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HUM. StockNews.com lowered Humana from a "buy" rating to a "hold" rating in a research note on Tuesday. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Truist Financial increased their price target on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a report on Monday, January 6th. JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Finally, Barclays increased their price objective on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, Humana presently has a consensus rating of "Hold" and an average price target of $285.68.

Remove Ads

Humana Stock Performance

Shares of HUM traded down $0.50 during mid-day trading on Friday, reaching $266.33. The company's stock had a trading volume of 1,963,596 shares, compared to its average volume of 1,713,717. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The stock has a market cap of $32.14 billion, a P/E ratio of 26.77, a PEG ratio of 2.05 and a beta of 0.57. The business has a 50-day simple moving average of $271.33 and a two-hundred day simple moving average of $277.52. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.33%. Humana's payout ratio is currently 35.58%.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.37% of the stock is currently owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.